SCHEMBL10273867

SCHEMBL10273867

CCOC[C@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3330177 1.00
SCHEMBL10273866 1.00
Hydrochloric Acid SCHEMBL18700859 0.98 CHRNA3 (0.44)
Hydrochloric Acid SCHEMBL3442784 0.98 CHRNA3 (0.44)
Hydrochloric Acid SCHEMBL3442787 0.98 CHRNA3 (0.44)
SCHEMBL22018875 0.94 LTA4H (0.42)
SCHEMBL12464310 0.94 LTA4H (0.42)
SCHEMBL19557798 0.91 CHRNB4 (0.40)
SCHEMBL18398793 0.86 CHRNA3 (0.46)
SCHEMBL25883074 0.85 CHRNA3 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107667097-B Separation of enantiomers of 3-ethylbicyclo [3.2.0] hept-3-en-6-one 诺瓦色生物公司 2021-02-12 CN disclosed
EP-3303308-B1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY SA (CH) 2019-10-09 EP disclosed
US-10150723-B2 Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one NOVASSAY S.A. (CH) 2018-12-11 US disclosed
EP-2792664-B1 OPTICAL RESOLUTION METHOD FOR BICYCLIC COMPOUND USING ASYMMETRIC CATALYST DAIICHI SANKYO CO LTD (JP) 2018-07-04 EP disclosed
US-20180134643-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY S.A. (CH) 2018-05-17 US disclosed
EP-3303308-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE Novassay SA (CH) 2018-04-11 EP disclosed
WO-2016146299-A1 SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE NOVASSAY SA (CH) 2016-09-22 WO disclosed
US-9035103-B2 Optical resolution methods for bicyclic compounds using asymmetric catalysts DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-05-19 US disclosed
US-9035103-B2 Optical resolution methods for bicyclic compounds using asymmetric catalysts DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-05-19 US disclosed
US-9035103-B2 Optical resolution methods for bicyclic compounds using asymmetric catalysts DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-05-19 US disclosed
US-20130065882-A1 VLA-4 inhibitory drug MACHINAGA NOBUO (JP) 2013-03-14 US disclosed
US-20120157437-A1 VLA-4 INHIBITORY DRUG DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-06-21 US disclosed
EP-2069354-B1 Aza-benzofuranyl compounds and methods of use GENENTECH INC (US) 2011-11-02 EP disclosed
US-20110190257-A1 BICYCLIC HETEROCYCLES AS MEK KINASE INHIBITORS GENETECH, INC. (US) 2011-08-04 US disclosed
EP-2099796-B1 AZA-INDOLYL COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2011-06-01 EP disclosed
US-20110124622-A1 ISOINDOLONES DERIVATIVES AS MEK KINASE INHIBITORS AND METHODS OF USE GENENTECH, INC. (US) 2011-05-26 US disclosed
EP-1499311-B1 SUBSTITUTED BENZAZOLES AND USE THEREOF AS RAF KINASE INHIBITORS NOVARTIS VACCINES & DIAGNOSTIC (US) 2009-11-04 EP disclosed
WO-2008067481-A1 AZA-INDOLYL COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-06-05 WO disclosed
WO-2008024724-A1 AZA-BENZOTHIOPHENYL COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-02-28 WO disclosed
WO-2008024725-A1 AZA-BENZOFURANYL COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-02-28 WO disclosed